Novartis’ Christine Brennan joins Vitae
pharmafile | July 26, 2010 | Appointment | Sales and Marketing |Â Â Vitae, appointment, sales and marketingÂ
US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer.
She has over 10 years industry experience and moves to Vitae from Novartis’ Institutes for BioMedical Research, where she served as executive director and head of strategy and operations for strategic alliances.
Vitae’s chief executive Jeffrey Hatfield commented: “We are very pleased to welcome Christine to Vitae at this stage of our growth. The life sciences industry is tracking on a path of tremendous change, centered around a rapidly increasing link – even co-dependency – between large pharma and biotech.
“Her successful partnering experiences in each, her proven track record of creating value through collaboration, and her strategic insights and leadership skills will all strongly contribute to Vitae’s continued maturation.”
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






